SECISBP2L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.132600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.139000E-01
Normal-vs-Stage2
4.051200E-01
Normal-vs-Stage3
4.395800E-02
Normal-vs-Stage4
8.146400E-01
Stage1-vs-Stage2
1.837210E-01
Stage1-vs-Stage3
2.625600E-02
Stage1-vs-Stage4
6.966200E-01
Stage2-vs-Stage3
1.319190E-01
Stage2-vs-Stage4
5.346000E-01
Stage3-vs-Stage4
8.749900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.907400E-01
Normal-vs-AfricanAmerican
9.608000E-01
Normal-vs-Asian
2.132400E-01
Caucasian-vs-AfricanAmerican
2.747400E-01
Caucasian-vs-Asian
2.755400E-01
AfricanAmerican-vs-Asian
1.692380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.441200E-01
Normal-vs-Female
5.180000E-01
Male-vs-Female
3.415600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.351400E-01
Normal-vs-Age(41-60Yrs)
8.850200E-01
Normal-vs-Age(61-80Yrs)
2.474800E-01
Normal-vs-Age(81-100Yrs)
4.932400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.381200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.663820E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.367900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.255720E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.839200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.211840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.101000E-01
Normal-vs-Daily Drinker
1.204380E-01
Normal-vs-Weekly Drinker
3.204400E-01
Normal-vs-Occasional Drinker
5.106800E-01
Normal-vs-Social Drinker
8.319400E-01
Non Drinker-vs-Daily Drinker
5.609400E-01
Non Drinker-vs-Weekly Drinker
8.863400E-01
Non Drinker-vs-Occasional Drinker
3.030200E-01
Non Drinker-vs-Social Drinker
2.100800E-01
Daily Drinker-vs-Weekly Drinker
5.504600E-01
Daily Drinker-vs-Occasional Drinker
1.397420E-01
Daily Drinker-vs-Social Drinker
1.165440E-01
Weekly Drinker-vs-Occasional Drinker
4.925200E-01
Weekly Drinker-vs-Social Drinker
3.127600E-01
Occasional Drinker-vs-Social Drinker
5.961800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.451800E-02
Normal-vs-Grade 2
1.160020E-02
Normal-vs-Grade 3
1.517650E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.685000E-01
Grade 1-vs-Grade 3
6.214000E-01
Grade 1-vs-Grade 4
4.451800E-02
Grade 2-vs-Grade 3
6.139200E-01
Grade 2-vs-Grade 4
1.160020E-02
Grade 3-vs-Grade 4
1.517650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.497200E-01
Normal-vs-NonDiabetic
3.405200E-01
Diabetic-vs-NonDiabetic
5.860200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.111800E-01
Normal-vs-NoPancreatitis
3.599200E-01
Pancreatitis-vs-NoPancreatitis
7.096200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.244000E-01
Normal-vs-N1
4.185200E-01
N0-vs-N1
7.429400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.455600E-01
Normal-vs-TP53-NonMutant
6.915800E-01
TP53-Mutant-vs-TP53-NonMutant
1.583200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
